Effects of sevelamer hydrochloride (Renagel®) and calcium acetate on controlling serum phosphorus in peritonel dialysis patients

被引：0
|
作者：
Evenepoel, Pieter
Selgas, Rafael
Duggal, Ajay
Kelly, Alison
Fan, Stanley L-S.
机构：
[1] Hosp Univ La Paz, Madrid, Spain
[2] Univ Ziekenhuizen, Louvain, Belgium
[3] Genzyme Europe Res, Cambridge, England
[4] Royal London Hosp, Renal Dept, London E1 1BB, England
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：496 / 496
页数：1
相关论文
共 50 条
  • [31] An international economic evaluation of sevelamer hydrochloride versus calcium-based phosphate binders in patients new to dialysis
    Taylor, M. J.
    Chaplin, S.
    Elgazzar, H.
    VALUE IN HEALTH, 2007, 10 (06) : A317 - A317
  • [32] Clinical Effects of the New Phosphorus Binder, Bixalomer in Hemodialysis Patients Switched From Sevelamer Hydrochloride
    Gen, Shikou
    Sasaki, Takaya
    Saito, Kanako
    Nobe, Kanako
    Nodaira, Yuka
    Ikeda, Naofumi
    THERAPEUTIC APHERESIS AND DIALYSIS, 2014, 18 : 8 - 12
  • [33] Impact of sevelamer hydrochloride on serum magnesium concentrations in hemodialysis patients
    Ikee, Ryota
    Toyoyama, Takayuki
    Endo, Toko
    Tsunoda, Masataka
    Hashimoto, Nobuo
    MAGNESIUM RESEARCH, 2016, 29 (04) : 184 - 190
  • [34] Epicardial adipose tissue volume increase in hemodialysis patients treated with sevelamer or calcium-based phosphate binders: a substudy of the Renagel in new dialysis trial
    Ko, Sung Min
    Zhang, Chao
    Chen, Zhengjia
    D'Marco, Luis
    Bellasi, Antonio
    Stillman, Arthur E.
    Block, Geoffrey
    Raggi, Paolo
    JOURNAL OF NEPHROLOGY, 2016, 29 (05) : 683 - 690
  • [35] Epicardial adipose tissue volume increase in hemodialysis patients treated with sevelamer or calcium-based phosphate binders: a substudy of the Renagel in new dialysis trial
    Sung Min Ko
    Chao Zhang
    Zhengjia Chen
    Luis D’Marco
    Antonio Bellasi
    Arthur E. Stillman
    Geoffrey Block
    Paolo Raggi
    Journal of Nephrology, 2016, 29 : 683 - 690
  • [36] Efficacy and side effects of Sevelamer hydrochloride as sole phosphate binder in peritoneal dialysis patients with severe hyperphosphatemia
    Lo, Wai Kei
    Cheng, Suk Wai
    Ng, Suk Yi
    Yip, Terence Pok-Siu
    Lam, Man Fai
    Tse, Kai Chung
    Lui, Sing Leung
    PERITONEAL DIALYSIS INTERNATIONAL, 2008, 28 (01): : 93 - 95
  • [37] The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients
    Chertow, GM
    Raggi, P
    McCarthy, JT
    Schulman, G
    Silberzweig, J
    Kuhlik, A
    Goodman, WG
    Boulay, A
    Burke, SK
    Toto, RD
    AMERICAN JOURNAL OF NEPHROLOGY, 2003, 23 (05) : 307 - 314
  • [38] A Real-world Cost-effectiveness Analysis of Sevelamer Versus Calcium Acetate in Korean Dialysis Patients
    Cho, Jang-Hee
    Jang, Hye Min
    Jung, Hee-Yeon
    Choi, Ji-Young
    Park, Sun-Hee
    Kim, Chan-Duck
    Yang, Chul Woo
    Jin, Dong-Chan
    Kim, Yong-Lim
    CLINICAL THERAPEUTICS, 2018, 40 (01) : 123 - 134
  • [39] Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs calcium carbonate in dialysis patients:: an open-label, randomized study
    Sadek, T
    Mazouz, H
    Bahloul, H
    Oprisiu, R
    El Esper, N
    El Esper, I
    Boitte, F
    Brazier, M
    Moriniere, P
    Fournier, A
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (03) : 582 - 589
  • [40] The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats
    Cozzolino, M
    Dusso, AS
    Liapis, H
    Finch, J
    Lu, Y
    Burke, SK
    Slatopolsky, E
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (09): : 2299 - 2308
12345